Enzyme Research
Studies from Montana State University further understanding of enzyme research
Published in Genetics and Environmental Law Weekly, December 22nd, 2007
"Mouse embryos homozygous for a targeted null mutation of the tynrd1 gene, encoding the cytosolic thioredoxin reductase, were viable at embryonic day 8.5 (E8.5) but not at E9.5. Histology revealed that txnrdl(-/-) cells were capable of proliferation and differentiation,- however, inutant embryos were smaller than wild-type littermates and failed to gastrulate. In situ marker gene analyses indicated that primitive streak mesoderm did not...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Law Weekly
More Articles from Genetics and Environmental Law Weekly
- Genetics & Genomics
Coriell Institute for Medical Research Launches Delaware Valley Personalized Medicine Project in Briefing Hosted by Rep. Rob Andrews - Hematology
ASH Honors Two Congressmen and NIDDK Director for their Public Service and Leadership in Hematology - Adenocarcinoma
Study data from University of Ljubljana, Center for Molecular Biology update understanding of adenocarcinoma - Adenoma
Study results from Q. Dai and colleagues broaden understanding of adenoma - Algorithms
Researchers from University of Utrecht report on findings in algorithms - Algorithms
Scientists at Jagiellonian University, Faculty of Chemistry detail research in algorithms - More from this issue of Genetics and Environmental Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
